Intravitreale Therapie mit Faricimab bei Morbus Coats: ein Fallbericht

• Literatur

• 1 Stephen M, Temkar S, Periyandavan J. et al. A Brief Review on Adult-Onset Coatsʼ Disease. Rom J Ophthalmol 2024; 68: 212
• 2 Bai J, Song Z, Li G. et al. Efficacy and Safety of Anti-Vascular Endothelial Growth Factor Drugs for Coatsʼ Disease Treatment: A Systematic Review. J Ocul Pharmacol Ther 2023; 39: 418-429
• 3 Dalvin LA. et al. Coats Disease: Clinical Features and Outcomes by Age Category in 351 Cases. J Pediatr Ophthalmol Strabismus 2019; 56: 288-296
• 4 Alsaggaf K, Jalloun M, Alkhotani W. et al. Three-Year Results of Management of Adult-Onset Coatsʼ Disease by Possibly Targeting Placental Growth Factor. Cureus 2020; 12: e10652
• 5 Shieh WS, Shah GK, Blinder KJ. Coatsʼ Disease-Related Macular Edema Treated with Combined Aflibercept and Laser Photocoagulation. Case Rep Ophthalmol Med 2017; 2017: 2824874
• 6 Zheng XX, Jiang YR. The effect of intravitreal bevacizumab injection as the initial treatment for Coatsʼ disease. Graefes Arch Clin Exp Ophthalmol 2014; 252: 35-42
• 7 Ramasubramanian A, Shields CL. Bevacizumab for Coatsʼ disease with exudative retinal detachment and risk of vitreoretinal traction. Br J Ophthalmol 2012; 96: 356-359
• 8 Zhang L, Ke Y, Wang W. et al. The efficacy of conbercept or ranibizumab intravitreal injection combined with laser therapy for Coatsʼ disease. Graefes Arch Clin Exp Ophthalmol 2018; 256: 1339-1346
• 9 Yang Q, Wie W, Shi X. et al. Successful use of intravitreal ranibizumab injection and combined treatment in the management of Coatsʼ disease. Acta Ophthalmol 2016; 94: 401-406
• 10 Patel NA, Berrocal AM, Murray TG. et al. Advanced Coatsʼ disease treated with intravitreal brolucizumab combined with laser photocoagulation. Am J Ophthalmol Case Rep 2020; 19: 100815